BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 16, 2010
View Archived Issues
HG-829 reverses resistance to antineoplastic agents in vitro and in vivo
Read More
ONO-013105 synergizes with rituximab in models of MCL and advances in phase I trial
Read More
New inhibitors claimed of PI3K-alpha and PI3K-gamma
Read More
Korean scientists divulge new amide compounds for treatment of bone disorders
Read More
Unigene and GSK amend licensing agreement and advance PTH program to phase II in osteoporosis
Read More
Phase I data support safety of BIIB-021 plus trastuzumab in HER2-positive breast cancer
Read More
MLN-0905 has antitumor effects in murine model of diffuse large B-cell lymphoma
Read More
Proton MRS can measure potential biomarkers for delirium in brain
Read More
MGN-1601 enters phase I/II study in advanced renal cancer
Read More
FDA grants Hemispherx an extension to modify its NDA for Ampligen
Read More
Rifadin capsules filed in Japan for nontuberculous mycobacterial disease
Read More
Orion identifies novel inhibitors of MT-SP1
Read More
GlaxoSmithKline claims new monoamine reuptake inhibitors
Read More
New modulators of metabotropic glutamate mGlu2 receptor discovered
Read More
Amarillo Biosciences completes enrollment in phase II trial of interferon alfa lozenges
Read More
Phase I safety data released on Immunovaccine's DPX-0907 cancer vaccine
Read More
Tesaro gains development rights to antiemetic rolapitant hydrochloride
Read More
Tolerx begins phase I TRX-518 trial for the treatment of cancer
Read More
FDA accepts for review sNDA for Definity in stress echocardiography
Read More
Phase IIa results reported for Creabilis' CT-327 in atopic dermatitis
Read More
Pharmasset begins exploratory trial of PSI-7977 in chronic hepatitis C
Read More
Vivus responds to FDA's complete response letter regarding Qnexa
Read More
Roflumilast approved in Canada for severe COPD in adults
Read More
Evolva begins multiple-ascending-dose phase I trial of EV-077
Read More
Kiacta enters phase III trial for prevention of renal decline in AA amyloidosis
Read More
